CKD (6407) Q3 2025 earnings summary

Executive summary

• Nine-month net sales rose 14.8% YoY to ¥115,082 million; operating profit increased 43.3% to ¥13,778 million and profit attributable to owners of parent rose 48.5% to ¥9,475 million.

• Growth was driven by semiconductor demand, especially generative AI investment, and HEV battery production.

• Full-year forecasts were revised upward to net sales of ¥156,500 million and profit attributable to owners of parent of ¥12,400 million.

Financial highlights

• Ordinary income was ¥14.1 billion, up ¥4.4 billion YoY; operating income rose ¥4.2 billion, including a ¥3.9 billion benefit from higher sales.

• Basic earnings per share increased to ¥141.91 from ¥95.59; comprehensive income was ¥9,661 million, up 18.5%.

• At December 31, 2024, total assets were ¥214,307 million and net assets were ¥134,508 million, up ¥6,021 million and ¥5,409 million, respectively, from March 31, 2024.

Outlook and guidance

• FY2024 forecast: net sales ¥156,500 million, operating profit ¥18,200 million, ordinary income ¥18.5 billion and profit attributable to owners of parent ¥12,400 million.

• The revised forecast increased sales by ¥8.5 billion, operating income by ¥0.7 billion, ordinary income by ¥1.0 billion and net income by ¥0.6 billion versus the initial outlook.

• Forecast includes automatic machinery sales of ¥24.5 billion and components sales of ¥132.0 billion; estimated full-year exchange rate is ¥145.0/US$.

• Continued semiconductor and automotive battery demand is expected; BEV investment and overseas market conditions remain uncertain.